Mumps – Vaccination. In: cdc.gov. 29. Mai 2015, abgerufen am 23. November 2017 (englisch).
doi.org
G. Amexis et al.: Quantitative mutant analysis of viral quasispecies by chip-based matrix-assisted laser desorption/ ionization time-of-flight mass spectrometry. In: Proc Natl Acad Sci USA. Band98, Nr.21, 2001, S.12097–12102, doi:10.1073/pnas.211423298, PMID 11593021, PMC 59774 (freier Volltext).
G. Amexis et al.: Sequence diversity of Jeryl Lynn strain of mumps virus: quantitative mutant analysis for vaccine quality control. In: Virology. Band300, Nr.2, 2002, S.171–179, doi:10.1006/viro.2002.1499, PMID 12350348.
J. Ivancic-Jelecki, M. Santak, D. Forcic: Variability of hemagglutinin-neuraminidase and nucleocapsid protein of vaccine and wild-type mumps virus strains. In: Infect Genet Evol., 2008, Band 8, Heft 5, S. 603–613. doi:10.1016/j.meegid.2008.04.007. PMID 18508415.
M. Şantak, C. Örvell, T. K. Gulija: Identification of conformational neutralization sites on the fusion protein of mumps virus. In: Journal of General Virology, 2015, 96, S. 982, doi:10.1099/vir.0.000059. PMID 25614584.
E Jane Homan, Robert D Bremel: Are cases of mumps in vaccinated patients attributable to mismatches in both vaccine T-cell and B-cell epitopes? In: Human Vaccines & Immunotherapeutics, 2014, 10, S. 290; doi:10.4161/hv.27139. PMID 24275080.
G. Amexis, N. Fineschi, K. Chumakov: Correlation of genetic variability with safety of mumps vaccine Urabe AM9 strain. In: Virology, 2001, Band 287, Heft 1, S. 234–41; doi:10.1006/viro.2001.1009. PMID 11504558.
google.ca
books.google.ca
Deborah Mitchell: The essential guide to children’s vaccines. St. Martin’s Press, New York 2013, ISBN 978-1-4668-2750-9, S.127 (google.ca).
G. Amexis et al.: Quantitative mutant analysis of viral quasispecies by chip-based matrix-assisted laser desorption/ ionization time-of-flight mass spectrometry. In: Proc Natl Acad Sci USA. Band98, Nr.21, 2001, S.12097–12102, doi:10.1073/pnas.211423298, PMID 11593021, PMC 59774 (freier Volltext).
G. Amexis et al.: Sequence diversity of Jeryl Lynn strain of mumps virus: quantitative mutant analysis for vaccine quality control. In: Virology. Band300, Nr.2, 2002, S.171–179, doi:10.1006/viro.2002.1499, PMID 12350348.
M. Beck et al.: Mumps vaccine L-Zagreb, prepared in chick fibroblasts. I. Production and field trials in Journal of Biological Standardization, Band 17, Heft 1, 1989, S. 85–90. PMID 2646300.
Y. Okuno et al.: Studies on the use of mumps virus for treatment of human cancer. In: Biken Journal. Band 21, Heft 2, 1978, S. 37–49. PMID 749908.
J. Ivancic-Jelecki, M. Santak, D. Forcic: Variability of hemagglutinin-neuraminidase and nucleocapsid protein of vaccine and wild-type mumps virus strains. In: Infect Genet Evol., 2008, Band 8, Heft 5, S. 603–613. doi:10.1016/j.meegid.2008.04.007. PMID 18508415.
U. Kulkarni-Kale et al.: Mapping antigenic diversity and strain specificity of mumps virus: a bioinformatics approach. In: Virology, 2007, Band 359, Heft 2, S. 436–446. PMID 17081582.
M. Şantak, C. Örvell, T. K. Gulija: Identification of conformational neutralization sites on the fusion protein of mumps virus. In: Journal of General Virology, 2015, 96, S. 982, doi:10.1099/vir.0.000059. PMID 25614584.
E Jane Homan, Robert D Bremel: Are cases of mumps in vaccinated patients attributable to mismatches in both vaccine T-cell and B-cell epitopes? In: Human Vaccines & Immunotherapeutics, 2014, 10, S. 290; doi:10.4161/hv.27139. PMID 24275080.
G. Amexis, N. Fineschi, K. Chumakov: Correlation of genetic variability with safety of mumps vaccine Urabe AM9 strain. In: Virology, 2001, Band 287, Heft 1, S. 234–41; doi:10.1006/viro.2001.1009. PMID 11504558.
pei.de
Mumps-Impfstoffe. Paul-Ehrlich-Institut, 22. Mai 2020, abgerufen am 4. Juni 2020.
Mitteilung der Ständigen Impfkommission beim Robert Koch-Institut:Empfehlung und wissenschaftliche Begründung für die Angleichung der beruflich indizierten Masern-Mumps-Röteln-(MMR-) und Varizellen-Impfung. In: Robert Koch-Institut (Hrsg.): Epidemiologisches Bulletin. Nr.2, 9. Januar 2020, S.3–22 (rki.de [PDF]).